Flow Cytometry in Evaluating Patients Undergoing Biotherapy

First Page		Document Content
CD5 CD81 B-cell prolymphocytic leukemia B-cell chronic lymphocytic leukemia Lymphocytic leukemia CD19 CD20		Flow Cytometry in Evaluating Patients Undergoing Biotherapy Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 312,70 KB Share Document on Facebook

	Human CD19 B-Cells INSTRUCTION MANUAL ZBM0073.01 SHIPPING CONDITIONS DocID: 1ocPG - View Document
	Product Datasheet Anti-CD19 antibody [EPR5906] ab134114 6 Images DocID: 1k0TT - View Document
	Additional File 1 - Supplementary Tables and Figure Table S1. Primary patient samples used for epigenetic analysis Sample type Age Sex Purification method* Purity** DocID: RvV5 - View Document
	BLINCYTO™ (blinatumomab) Drug Class: Bispecific CD19-directed CD3 T-cell engager Amgen Inc. DocID: J9N5 - View Document
	Personalized Medicine Update Discussion of Recent Results on Protocol 793 titled: Pilot Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRζ and 4-1BB Signaling Domains in Patients wi DocID: GezP - View Document